The effects of 1-year treatment with a herbst mandibular advancement splint on obstructive sleep apnea, oxidative stress, and endothelial function

Chest

Volumn 131, Issue 3, 2007, Pages 740-749

  Itzhaki, Sarah ^a   Dorchin, Hezi ^a   Clark, Glenn ^b   Lavie, Lena ^a   Lavie, Peretz ^a   Pillar, Giora ^a,c  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Endothelial dysfunction; Obstructive sleep apnea; Oral appliance; Oxidative stress

Indexed keywords

MALONALDEHYDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; LONG TERM CARE; MALE; MANDIBULAR ADVANCEMENT SPLINT; OXIDATIVE STRESS; PATIENT SATISFACTION; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; SNORING; SPLINT; TREATMENT OUTCOME;

EID: 33947377125     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-0965     Document Type: Article

References (51)

1. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep disordered breathing and hypertension. N Engl J Med 2000; 342:1738-1784
2. Peled N, Abinader EG, Pillar G, et al. Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive air pressure treatment. J Am Coll Cardiol 1999; 15:1744-1749
3. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnea syndrome as a risk factor for hypertension: population study. BMJ 2000; 320:479-482
4. Peker Y, Hedner J, Norum J, et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002; 166:159-165
5. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: Sleep Heart Health Study. JAMA 2000; 283:1829-1836
6. Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 2003; 290:1906-1914
7. Kato M, Roberts-Thompson P, Phillips BG, et al. Impairment of endothelium dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000; 102:2607-2610
8. Imadojemo VA, Gleeson K, Quraishi SA, et al. Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive airway pressure therapy. Am J Respir Crit Care Med 2002; 165:950-953
9. Nieto FJ, Herrington DM, Redline S, et al. Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J Respir Crit Care Med 2004; 169:354-360
10. Ip MSM, Tse HF, Lam B, et al. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004; 169:348-353
11. Kraiczi H, Caidahl K, Samuelsson A, et al. Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep. Chest 2001; 119:1085-1091
12. Itzhaki S, Lavie L, Pillar G, et al. Endothelial dysfunction in obstructive sleep apnea measured by peripheral arterial tone response in the finger to reactive hyperemia. Sleep 2005; 28:594-600
13. Drager LF, Bortolotto LA, Lorenzi MC, et al. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2005; 172:613-618
14. Minuguchi K, Yokoe T, Tazaki T, et al. Increased carotid intima-media thickness and serum inflammatory markers of obstructive sleep apnea. Am J Respir Crit Care Med 2005; 172:625-630
15. Lavie L, Vishnevsky A, Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 2004; 27:123-128
16. Christou K, Moulas AM, Pastaka C, et al. Antioxidant capacity in obstructive sleep apnea patients. Sleep Med 2003; 4:225-228
17. Yamauchi M, Nakano H, Maekawa J, et al. Oxidative stress in obstructive sleep apnea. Chest 2005; 127:1674-1679
18. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002; 165:934-939
19. Carpagnano GE, Kharitonov SA, Resta O, et al. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 2003; 124:1386-1392
20. Schulz R, Mahmoudi S, Hattar K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000; 162:566-570
21. Ohike Y, Kozaki K, Iijima K, et al. Amelioration of vascular endothelial dysfunction in obstructive sleep apnea by nasal continuous positive airway pressure-possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine. Circ J 2005; 69:221-226
22. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107:68-73
23. Pepperell JC, Ramdassingh-Dow S, Croshwaite N. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnea: a randomized parallel trial. Lancet 2002; 359:204-210
24. Sajkov D, Wang T, Saunders NA, et al. Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2002; 165:152-158
25. Marin JM, Carrizo SJ, Vicente E, et al. Long term cardiovascular outcomes in men with obstructive sleep apnea-hypopnea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365:1046-1053
26. Engleman HM, Wild MR. Improving CPAP use by patients with the sleep apnea/hypopnea syndrome (SAHS). Sleep Med Rev 2003; 7:81-99
27. Randerath WJ, Heise M, Hinz R, et al. An individually adjustable oral appliance vs continuous positive airway pressure in mild-to-moderate obstructive sleep apnea syndrome. Chest 2002; 122:569-575
28. Hoekema A, Stegenga B, de Bont LGM. Efficacy and comorbidity of oral appliances in the treatment of obstructive sleep apnea hypopnea: a systemic review. Crit Rev Oral Biol Med 2004; 15:137-155
29. Lim J, Lasserson TJ, Fleetham J, et al. Oral appliances for obstructive sleep apnea (review). Cochrane Database Syst Rev (database online). Issue 4, 2004
30. Clark GT, Blumenfeld I, Yoffe N, et al. A crossover study comparing the efficacy of continuous positive airway pressure with anterior mandibular positioning devices on patients with obstructive sleep apnea. Chest 1996; 109:1477-1483
31. Lawton HM, Battagel JM, Kotecha B. A comparison of the twin block and herbst mandibular advancement splints in the treatment of patients with obstructive sleep apnea: a prospective study. Eur J Orthod 2005; 27:82-90
32. Warunek SP. Oral appliance therapy in sleep apnea syndromes: a review. Semin Orthod 2005; 10:73-89
33. Gostsopoulos H, Kelly JJ, Cistulli PA. Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized controlled trial. Sleep 2004; 27:934-941
34. Barnes M, Douglas McEvoy R, Banks S, et al. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med 2004; 170:556-664
35. Rechtschaffen A, Kales A, eds. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles, CA: University of California Los Angeles, 1968
36. American Academy of Sleep Medicine. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurements techniques in clinical research; the report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22:667-689
37. Bar A, Pillar G, Dvir I, et al. Evaluation of a portable device based on peripheral arterial tone for unattended home sleep study. Chest 2003; 123:695-703
38. Hedner J, Pillar G, Pittman SD, et al. A novel adaptive wrist actigraphy algorithm for sleep-wake assessment in sleep apnea patients. Sleep 2004; 27:1560-1566
39. Kuvin JT, Patel AR, Sliney KA, et al. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J 2003; 146:168-174
40. Bonetti PO, Barsness GW, Keelan PC, et al. Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol 2003; 41:1761-1768
41. Buege JA, Aust SD. Microsmal lipid peroxidation. Methods Enzymol 1978; 52:302-310
42. El-Saadani M, Esterbauer H. El-Sayed M, et al. Aspectrophotmetric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 1989; 30:627-630
43. Gan KN, Smolen A, Eckerson HW, et al. Purification of human serum paraoxonase/arylesterase: evidence for one esterase catalysing both activities. Drug Metab Dispos 1991; 19:100-106
44. White DP. Pathogenesis of obstructive and central sleep apnea. Am J Respir Crit Care Med 2005; 172:1363-1370
45. Bloch K, Iseli A, Zhang J, et al. A randomized controlled crossover trial of two oral appliances for sleep apnea treatment. Am J Respir Crit Care Med 2000; 162:246-251
46. Lavie L. Obstructive sleep apnoea: an oxidative stress disorder. Sleep Med Rev 2003; 7:35-51
47. Fisher D, Pillar G, Malhotra A, et al. Long-term follow-up on treated and untreated patients with sleep apnea. Respir Med 2002; 96:337-343
48. Campos-Rodriguez F, Peña-Griñan N, Reyes-Nuñez N, et al. Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest 2005; 128:624-633
49. Ferguson KA, Cartwright R, Rogers R, et al. Oral appliances for snoring and obstructive sleep apnea: a review. Sleep 2006; 29:244-262
50. Pittman SD, Pillar G, Berry R, et al. Follow-up assessment of CPAP efficacy in patients with obstructive sleep apnea using an ambulatory device based on peripheral arterial tonometry. Sleep Breath 2006; 10:123-131
51. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004; 109(suppl):27-32